Clearside Biomedical Inc
NASDAQ:CLSD
Clearside Biomedical Inc
NASDAQ:CLSD
Price:
0.41
USD
-26.96%
Market Cap:
$4.7m
Relative Value
The Relative Value of one
CLSD
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.41 USD,
Clearside Biomedical Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CLSD Relative Value
HIDDEN
Multiples Across Competitors
CLSD Competitors Multiples
Clearside Biomedical Inc Competitors
Clearside Biomedical Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Clearside Biomedical Inc
NASDAQ:CLSD
|
4.7m USD | 1.1 | -0.2 | 0.2 | 0.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
975.1B USD | 15.1 | 47.7 | 32.1 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.4B USD | 6.3 | 22.3 | 15.4 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP | 5.5 | 31.7 | 17.5 | 24.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.1B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.9B USD | 2.6 | 17.8 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
